Development of iagnostic tool of Arzheimer's discase with use of platelet factor XI and Amyloid beta-protein precursor

使用血小板因子 XI 和淀粉样 β 蛋白前体开发阿茨海默病诊断工具

基本信息

  • 批准号:
    05671934
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1993
  • 资助国家:
    日本
  • 起止时间:
    1993 至 1994
  • 项目状态:
    已结题

项目摘要

We investigated the function of Amyloid beta-protein precursor (APP) and diagnosis for Arzheimer's disease (AD) and vascular disease (VD) with use of vascular injury markers and APP.And we developed the new diagnostic markers with use of APP and other platelet activation markers for vascular injury.The detection of platelet activation inclinical blood sample was generally performed by beta-thromboglobulin and so on. However, there was a few reports of sensitive and specific assay methods, such as flow eytometric analysis. We first investigated the association of APP and platelet derived microparticles in thrombotic diseases, and APP-positive microparticles was significantly greater in the patients with cerebral infarction, diabetes, and uremia. These results suggested that micropartiele APP may have a regulatory influence on coagulation abonormality and be a new marker for vascular injury. Therefore, we next investigate whether platelet activation could be quantitatively detected in the patients with arteriosclerosis, which were graded by clinical severity. In the patients with coronary artery disease, who were diagnosed the severity with use of angiography, the expression of platelet activation specific markers such as p-selectin (CD62P) and CD63 were significantly increased and especially in three-vessel disease. These our findings indicate that platelet activation occurs in the patients with severe coronary artery stenosis.We already reported the purification of APP,whoch was one of the key substances of the pathophysiology of AD,from human activated platclets. And we separately detected the activation of factor XI in coronary artery disease. The results in this project suggested that APP expressed on the surface of activated platelet without relcase. More study is needed to establish the development of new assay method for the AD to distiguish VD using platelet activation.
我们利用血管损伤标志物和淀粉样β蛋白前体(APP)研究APP的功能及对阿尔茨海默病(AD)和血管病(VD)的诊断,并将APP与其他血小板活化标志物一起开发新的血管损伤诊断标志物。有一些敏感和特异的检测方法的报道,如流式细胞仪分析。我们首先研究了APP和血小板衍生微粒在血栓性疾病中的相关性,并且APP阳性微粒在脑梗死、糖尿病和尿毒症患者中显著更大。结果提示,微粒APP可能对凝血功能异常有调节作用,可作为血管损伤的一个新的标志物。因此,我们接下来研究是否可以在动脉硬化患者中定量检测血小板活化,其根据临床严重程度分级。经冠状动脉造影确诊为冠心病的患者,血小板活化特异性标志物P-选择素(CD 62 P)、CD 63的表达均明显增高,尤以三支病变者明显。本实验室已报道了从人血小板中分离纯化出与AD病理生理有关的重要物质APP。并分别检测了冠心病患者凝血因子XI的激活情况。本实验结果提示,APP在活化血小板表面表达,且无释放。需要进一步研究建立新的AD检测方法,以通过血小板活化来鉴别VD。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T.Murakami et al.: "Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease" European Journal of clinical lnvestigation. 26. 996-1003 (1996)
T.Murakami 等人:“冠状动脉疾病患者血小板活化标记物 CD62P 和 CD63 的流式细胞术分析”《欧洲临床调查杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Y.Komiyama et al.: "Activated coagulation factors in Verious thrombotic diseases" Japanese Journal of Clinical Pathology. 43. 1195-1200 (1995)
Y.Komiyama 等人:“多种血栓性疾病中的活化凝血因子”日本临床病理学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Murakami and Y.Komiyama et al.: "Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery discase" European Journal of Clinical Investigation. 26. 996-1003 (1996)
T.Murakami 和 Y.Komiyama 等人:“冠状动脉疾病患者血小板活化标记物 CD62P 和 CD63 的流式细胞分析”《欧洲临床研究杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Nomura & Y.Komiyama,et al.: "Amyloid β-Protein Precursor-rich Microparticles in Thrombotic Disease" Thrombosis and Haemostasis. 72. 519-522 (1994)
S. Nomura 和 Y. Komiyama 等人:“血栓性疾病中富含淀粉样 β-蛋白前体的微粒”《血栓形成和止血》72. 519-522 (1994)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KOMIYAMA Yutaka其他文献

KOMIYAMA Yutaka的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KOMIYAMA Yutaka', 18)}}的其他基金

Protective effects of endogenous digitalislike factor on the injury of kidney by aldosterone
内源性洋地黄样因子对醛固酮肾损伤的保护作用
  • 批准号:
    21590643
  • 财政年份:
    2009
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical Chemistry of Newly-found Esterase for Endogenous Digitalis-like Factor
新发现的内源性洋地黄样因子酯酶的临床化学
  • 批准号:
    18590543
  • 财政年份:
    2006
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical Chemistry of Newly-found Endogenous Bufalin Isomer in Saliva
唾液中新发现的内源性蟾蜍灵异构体的临床化学
  • 批准号:
    16590467
  • 财政年份:
    2004
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of unknown circulating anticoagulant cases
不明循环抗凝病例分析
  • 批准号:
    13672435
  • 财政年份:
    2001
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Estimation of re-stenosis after PTCA by laboratory test of coagulation and fibrinolysis.
通过凝血和纤溶实验室测试评估 PTCA 后的再狭窄。
  • 批准号:
    10672191
  • 财政年份:
    1998
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Cerebral infarction treatment strategy using collagen-like "triple helix peptide" containing functional amino acid sequence
含功能氨基酸序列的类胶原“三螺旋肽”治疗脑梗塞策略
  • 批准号:
    23K06972
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Type I Interferon Mediated Restoration of Brain Endothelial Cell Function after Cerebral Infarction
I型干扰素介导脑梗塞后脑内皮细胞功能的恢复
  • 批准号:
    10606276
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Cell therapy research using human umbilical cord blood-derived hemangioblast-like cells for the treatment of cerebral infarction
人脐带血成血管样细胞治疗脑梗塞的细胞治疗研究
  • 批准号:
    22K09221
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
In vitro cerebral infarction model using assembloid culture system
使用Assembloid培养系统建立体外脑梗死模型
  • 批准号:
    22K16685
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of innovative treatments using next-generation exosomes for cerebral infarction
使用下一代外泌体开发脑梗塞创新疗法
  • 批准号:
    22K09239
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Prospective study for cerebral infarction after transcatheter aortic valve replacement in low risk patients
低危患者经导管主动脉瓣置换术后脑梗死的前瞻性研究
  • 批准号:
    22K16563
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Clinical study to prevent the pulmonary vein stump thrombus and cerebral infarction after left side pulmonary resection
预防左侧肺切除术后肺静脉残端血栓及脑梗死的临床研究
  • 批准号:
    21K16522
  • 财政年份:
    2021
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of new function of Noggin, a BMP inhibitor, in cerebral infarction and spinal cord injury
阐明BMP抑制剂Noggin在脑梗塞和脊髓损伤中的新功能
  • 批准号:
    21H02655
  • 财政年份:
    2021
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Creation of cerebroprotective therapy in cerebral infarction by targeting IL-27 and IL-27-related molecules
以IL-27及IL-27相关分子为靶点创建脑梗死脑保护疗法
  • 批准号:
    20K17973
  • 财政年份:
    2020
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Recovery of paralysis after cerebral infarction and analysis of molecular mechanisms based on O-GlcNAc modification in the brain
脑梗塞后瘫痪的恢复及基于O-GlcNAc脑内修饰的分子机制分析
  • 批准号:
    20K11197
  • 财政年份:
    2020
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了